GB2208599A - Oral anti-malarial treatment - Google Patents

Oral anti-malarial treatment Download PDF

Info

Publication number
GB2208599A
GB2208599A GB8725175A GB8725175A GB2208599A GB 2208599 A GB2208599 A GB 2208599A GB 8725175 A GB8725175 A GB 8725175A GB 8725175 A GB8725175 A GB 8725175A GB 2208599 A GB2208599 A GB 2208599A
Authority
GB
United Kingdom
Prior art keywords
treatment
epsom
ferro
phosphate
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8725175A
Other versions
GB8725175D0 (en
GB2208599B (en
Inventor
Paolina Artine Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB8725175A priority Critical patent/GB2208599B/en
Publication of GB8725175D0 publication Critical patent/GB8725175D0/en
Publication of GB2208599A publication Critical patent/GB2208599A/en
Application granted granted Critical
Publication of GB2208599B publication Critical patent/GB2208599B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oral compositions for malaria treatment contain cloves, Epsom-salts, Ferro-phosphate, cinnamon, total calcium and acid soluble calcium. The proportions are generally one part by weight each of Epsom-salts and Ferro-phosphate, and one half part of weight each of the other ingredients.

Description

"Oral Anti-Malarial Treatment" This invention relates to a treatment which has been found effective (and free of side or after effects) against Malaria, and which has properties that will combat other blood diseases.
This invention is for administration comprising of the following ingredients: Epsom-salts Ferro-Phosphate Cinnamon Cloves Total Calcium Acid Soluble calcium This treatment comprises one part by weight each of Epsom-salts, Ferro-phosphate and one half part by weight each of the other four ingredients. It is to be understood that these proportions may be varied withim limits, but no more than 10g variation will be permissible.
The ingredients do not have to be mixed in any particular order or treated in any way other than being very finely ground, then thoroughly mixed, they can be compressed into pills or in capsules.
For a batch of pills the amount of each part of the first two ingredients may be 800 mg and each part of the other four ingredients 400 mg This amount will make twelve adult pills and twenty four children's pills. The dosage for adults is two pills per day for six days, and for children the dosage is two per day for twelve days, the treatment should be commenced when the initial fever drops.

Claims (3)

Claims
1. A treatment for oral administration comprising the following ingredients: Epsom-salts, Ferro-phosphate, Cinnamon, Cloves, Total Calcium, Acid Soluble Calcium
2. A treatment as claimed in Claim 1 wherein the treatment comprises one part by weight each of Epsom-salts and Ferro-phosphate, and one half part by weight each of the other ingredients
3. A treatment claimed in Claim 2 wherein the variation is within 10%
GB8725175A 1987-05-05 1987-05-05 Oral anti-malarial treatment Expired - Lifetime GB2208599B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8725175A GB2208599B (en) 1987-05-05 1987-05-05 Oral anti-malarial treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8725175A GB2208599B (en) 1987-05-05 1987-05-05 Oral anti-malarial treatment

Publications (3)

Publication Number Publication Date
GB8725175D0 GB8725175D0 (en) 1987-12-02
GB2208599A true GB2208599A (en) 1989-04-12
GB2208599B GB2208599B (en) 1992-08-26

Family

ID=10625984

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8725175A Expired - Lifetime GB2208599B (en) 1987-05-05 1987-05-05 Oral anti-malarial treatment

Country Status (1)

Country Link
GB (1) GB2208599B (en)

Also Published As

Publication number Publication date
GB8725175D0 (en) 1987-12-02
GB2208599B (en) 1992-08-26

Similar Documents

Publication Publication Date Title
US5874094A (en) Cream formulation for topical application
US4749572A (en) Pharmaceutical preparations
CA1243605A (en) Antidiarrheal compositions and use thereof
US4585656A (en) Treatment of herpes
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
EP0403048A3 (en) Medicated compositions containing sucralfate and processes for their production
JPS6463522A (en) Pharmaceutical composition for treating and preventing gallstone and gall deficient indigestion
US3428728A (en) Timed release sublingual medications
US3721735A (en) Compositions for and method of lowering cholesterol levels
GB2098066A (en) Vitamin d3 derivatives for preventing parturient paresis in dairy cattle
EP0629400A1 (en) Idebenone compositions for treating Alzheimer's disease
US3008874A (en) Pharmaceutical compositions
US2449184A (en) Oral fluoride-vitamin preparation
US7138148B2 (en) Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia
GB2208599A (en) Oral anti-malarial treatment
US2847346A (en) Laxative compositions contaqining dioctyl sodium sulfosuccinate and 1, 8-dihydroxyanthraquinone
US3160562A (en) Composition containing ergotamine, caffeine and hydantoin derivatives for cephalalgia
Redpath et al. The side effects of carbamazepine therapy
US2854376A (en) Antacid composition
EP0372676A1 (en) Therapeutic preparation and method
US4919933A (en) Method for the treatment of dental disease
Simon et al. Administration of obidoxime tablets to man: plasma levels and side reactions
RU1826910C (en) Biostimulating agent
AU629520B2 (en) A medicament
CA1179267A (en) Composition for relieving toothache pain

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960818